Evidence map›Paper›PMID 28350860›Full record

ArticlePloS one2017

Uniquely altered transcripts are associated with immune preservation in HIV infection.

Michelle Zanoni, Ítalo Karmann Aventurato, James Hunter, Maria Cecilia Araripe Sucupira, Ricardo Sobhie Diaz

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Michelle ZanoniRetrovirology Laboratory, Department of Medicine, Federal University of Sao Paulo, Sao Paulo, Brazil.
Ítalo Karmann AventuratoRetrovirology Laboratory, Department of Medicine, Federal University of Sao Paulo, Sao Paulo, Brazil.
James HunterRetrovirology Laboratory, Department of Medicine, Federal University of Sao Paulo, Sao Paulo, Brazil.
Maria Cecilia Araripe SucupiraRetrovirology Laboratory, Department of Medicine, Federal University of Sao Paulo, Sao Paulo, Brazil.
Ricardo Sobhie DiazRetrovirology Laboratory, Department of Medicine, Federal University of Sao Paulo, Sao Paulo, Brazil.
Universidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mechanisms underlying host HIV control hold much promise in the search for a functional HIV cure. We investigated the host genomic signatures in elite controllers or rapid progressors following recent infection and the correlates of immune reconstitution during combination antiretroviral therapy. We characterized the HIV-specific longitudinal host transcriptional response of peripheral blood mononuclear cells from elite controllers, rapid progressors, immune responders and non-responders using a RT-qPCR array in a cohort of recently HIV-infected Brazilian individuals. The elite controllers expressed unique transcripts early in infection that were closely associated with specialized cross-presentation between XCR1+ DCs and antigen-specific CD8+ T cells (XCL1). The natural suppression of HIV was also associated with the highly functional co-expression of cytokines and chemokines (CCL2, TNF and IL-10) concomitant with the maintenance of important anti-inflammatory and anticoagulant properties (Antithrombin III). Immune responders exhibited exclusively upregulated mRNAs possibly related to stem cell mobilization before combination antiretroviral therapy (neutrophil elastase). Our longitudinal approach to gene expression permitted us to discover previously unrecognized determinants that contribute to natural or antiretroviral-mediated HIV-1 immune control.

Indexed as

Antiretroviral Therapy, Highly ActiveAntithrombin IIIAntiviral AgentsBrazilCD4 Lymphocyte CountChemokinesCohort StudiesCross-PrimingCytokinesGene Expression ProfilingHIV-1HIV InfectionsHIV Long-Term SurvivorsHLA-B AntigensHost-Pathogen InteractionsHumansAntithrombin IIIAntiviral AgentsChemokinesCytokinesHLA-B Antigens

Identifiers

PMID28350860
PMCPMC5370105
OpenAlexW2600247545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.